Universität zu Köln

2018

Cohen, J. B., Engert, A., Ansell, S. M., Younes, A., Trneny, M., Savage, K. J., Ramchandren, R., Collins, G. P., Fanale, M. A., Armand, P., Zinzani, P. L., de Boer, J. P., Shipp, M. A., Santoro, A., Timmerman, J. M., Sacchi, M., Sy, O. and Kuruvilla, J. (2018). Nivolumab Treatment Beyond Investigator-Assessed Progression: Outcomes in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma From the Phase 2 CheckMate 205 Study. Br. J. Haematol., 181. S. 87 - 89. HOBOKEN: WILEY. ISSN 1365-2141

Engert, A., Domingo Domenech, E., Rueda, A., Armand, P., Trneny, M., Feldman, T., Ansell, S., Provencio, M., Jaeger, U., Cohen, J. B., Savage, K. J., Willenbacher, W., Sacchi, M., Sumbul, A. and Ramchandren, R. (2018). Nivolumab plus doxorubicin, vinblastine, and dacarbazine (N-AVD) for newly diagnosed advanced-stage classical Hodgkin lymphoma (cHL): results from Cohort D of the phase 2 CheckMate 205 study. Oncol. Res. Treat., 41. S. 273 - 274. BASEL: KARGER. ISSN 2296-5262

2017

Jaeger, U., Engert, A., Fanale, M., Santoro, A., Armand, P., Ansell, S., Zinzani, P. L., Timmerman, J. M., Collins, G. P., Ramchandren, R., Cohen, J. B., De Boer, J. P., Kuruvilla, J., Savage, K. J., Trneny, M., Rodig, S., Shipp, M., Kato, K., Sumbul, A., Farsaci, B. and Younes, A. (2017). Nivolumab for relapsed/refractory classical Hodgkin lymphoma after autologous transplantation: full results after extended follow-up of the multicohort, multicenter phase 2 CheckMate 205 trial. Oncol. Res. Treat., 40. S. 13 - 15. BASEL: KARGER. ISSN 2296-5262

2016

Zinzani, P. L., Engert, A., Younes, A., Santoro, A., Ansell, S., Timmerman, J., Collins, G., Armand, P., Savage, K. J., Trneny, M., Fanale, M., Kuruvilla, J., Cohen, J. B., Shipp, M., Rodig, S., Kato, K., Sumbul, A., Farsaci, B. A. and Ratanatharathorn, V. (2016). CHECKMATE 205 COHORT C: NIVOLUMAB IN PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA AFTER PRIOR BRENTUXIMAB VEDOTIN AND AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION. Haematologica, 101. S. 43 - 45. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078